Asia-inclusive drug development leveraging principles of ICH E5 and E17 guidelines: Case studies illustrating quantitative clinical pharmacology as a foundational enablerCTS-CLINICAL AND TRANSLATIONAL SCIENCEIF2.82024-10-240OA
Model-informed Evidence for Clinical Non-inferiority of Every-2-Weeks Versus Standard Weekly Dosing Schedule of Cetuximab in Metastatic Colorectal CancerCLINICAL PHARMACOLOGY & THERAPEUTICSIF5.52024-08-120OAAI
Asia-Inclusive Global Development of Enpatoran: Results of an Ethno-Bridging Study, Intrinsic/Extrinsic Factor Assessments and Disease Trajectory Modeling to Inform Design of a Phase II Multiregional Clinical TrialCLINICAL PHARMACOLOGY & THERAPEUTICSIF5.52024-02-283OAAI
A phase I study of sorafenib in combination with S-1 plus cisplatin in patients with advanced gastric cancer索拉非尼联合S-1加顺铂治疗晚期胃癌的I期研究GASTRIC CANCERIF5.12013-03-2717OA